Literature DB >> 15916874

Development of a simple method for predicting the levels of di(2-ethylhexyl) phthalate migrated from PVC medical devices into pharmaceutical solutions.

Yuji Haishima1, Fumie Seshimo, Tae Higuchi, Haruko Yamazaki, Chie Hasegawa, Shun-ichiro Izumi, Tsunehisa Makino, Keisuke Nakahashi, Rie Ito, Koichi Inoue, Yoshihiro Yoshimura, Koichi Saito, Takeshi Yagami, Toshie Tsuchiya, Hiroyuki Nakazawa.   

Abstract

This study deals with the development of a simple method for predicting the elution levels of di-2-ethylhexyl phthalate (DEHP) from medical devices made of polyvinyl chloride (PVC) by using the physicochemical properties of pharmaceutical injections as a marker. GC-MS analysis showed that the release of DEHP from medical grade PVC product was concentration-dependently increased by extraction with two kinds of lipophilic injections (Sandimmun and Prograf) and three kinds of surfactants (HCO-60, Tween 80, and SDS). The solubility of lipophilic pigments such as Sudan III, methyl yellow, and 1,4-diamino-anthraquinone against these solutions were also increased in a concentration-dependent manner, in which methyl yellow showed the highest response regarding the increase of optical density (O.D.). Further, electrical conductivity and static contact angle to the PVC sheet of the solutions were also increased or decreased in the same manner. As a result of the comparative study, significant correlation was found between DEHP release levels and these three physicochemical properties, particularly methyl yellow solubility, of the solutions tested. To evaluate the relationship in detail, DEHP release levels from PVC tubing and methyl yellow solubility of 53 injections used in gynecologic and obstetric fields were determined. None of the hydrophilic medicines showed any significant release of DEHP, and all showed low solubility of methyl yellow. On the other hand, the lipophilic medicines releasing a large amount of DEHP showed high solubility of methyl yellow (greater than O.D. 0.8). These results indicate that a significant proportional relationship exists between DEHP release potency and methyl yellow solubility of pharmaceutical solutions, and the risk of DEHP exposure to the patients administered pharmaceuticals through transfusion set could be easily predicted by the solubility test without complicated elution tests of DEHP using GC-MS or LC-MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916874     DOI: 10.1016/j.ijpharm.2005.04.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

2.  Pilot study on novel blood containers with alternative plasticizers for red cell concentrate storage.

Authors:  Yuki Morishita; Yusuke Nomura; Chie Fukui; Tsuyoshi Kawakami; Toshiyuki Ikeda; Tomokazu Mukai; Toshiyasu Yuba; Ken-Ichi Inamura; Hisatoki Yamaoka; Ken-Ichi Miyazaki; Hitoshi Okazaki; Yuji Haishima
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

3.  Stability study of docetaxel solution (0.9%, saline) using Non-PVC and PVC tubes for intravenous administration.

Authors:  Kang Hoon Park; Dong June Chung
Journal:  Biomater Res       Date:  2015-01-28

4.  Evaluation of the Di(2-ethylhexyl)phthalate released from polyvinyl chloride medical devices that contact blood.

Authors:  Hongyu Luo; Guangyu Sun; Yanping Shi; Yong Shen; Kai Xu
Journal:  Springerplus       Date:  2014-01-29

5.  Exposure to Di-(2-ethylhexyl) Phthalate During Perinatal Period Gender-Specifically Impairs the Dendritic Growth of Pyramidal Neurons in Rat Offspring.

Authors:  Mingdan You; Jing Dong; Yuanyuan Fu; Zhangzhao Cong; Hui Fu; Lingling Wei; Yi Wang; Yuan Wang; Jie Chen
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.